inspira-technologies.com (IINN) - Cash per Single Share

Inspira Technologies Oxy is at the start of a technological cycle where the asset's value is determined by clinical trial results. High barriers to entry are ensured by exclusive patents and strict FDA control. The free cash flow per share chart confirms solvency, while 0.07 captures the current state of the parameter. Business stability relies on Israeli developments of alternatives to ventilators.
Comprehensive metric breakdowns and analytics for Inspira Technologies Oxy B.H.N. Ltd. (IINN)

This metric is calculated as the ratio of total liquidity to the number of shares, providing a real-time assessment of capital dynamics. The metric measures the volume of available resources, where excess funds minimize default risks but limit growth potential. For Inspira Technologies (IINN), these reserves are critical when launching non-invasive ART systems into the market. Analyzing this cash cushion per share allows for an evaluation of the company's financial stability during the commercialization of its innovations.